PRDX5 and T-cell leukemia: In addition, studies have suggested that AZA acts as a TRX (thioredoxin) reductase inhibitors and has a potential therapeutic usefulness for treatment of HTLV-1(+) T-cell leukemia (U-Taniguchi et al., 1995).